Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance.
Benjamin C RemingtonStef J KoppelmanTodd D GreenGideon LackGraham C RobertsDianne E CampbellPublished in: Allergy (2021)